Lv11
60 积分 2026-04-26 加入
Evolving cell states and oncogenic drivers during the progression of IDH-mutant gliomas
10小时前
待确认
Long-term efficacy of early versus delayed radiotherapy for low-grade astrocytoma and oligodendroglioma in adults: the EORTC 22845 randomised trial
10小时前
已完结
IDH inhibition in gliomas: from preclinical models to clinical trials
10小时前
已完结
Observation after surgery for low grade glioma: long-term outcome in the light of the 2016 WHO classification
1个月前
已完结
Rethinking extent of resection of contrast-enhancing and non-enhancing tumor: different survival impacts on adult-type diffuse gliomas in 2021 World Health Organization classification
1个月前
已完结
IDH-mutant gliomas arise from glial progenitor cells harboring the initial driver mutation
1个月前
已完结
Vorasidenib in IDH1-mutant or IDH2-mutant low-grade glioma (INDIGO): secondary and exploratory endpoints from a randomised, double-blind, placebo-controlled, phase 3 trial
2个月前
已完结
Vorasidenib in IDH1-mutant or IDH2-mutant low-grade glioma (INDIGO): secondary and exploratory endpoints from a randomised, double-blind, placebo-controlled, phase 3 trial
2个月前
已完结
Vorasidenib in IDH1-mutant or IDH2-mutant low-grade glioma (INDIGO): secondary and exploratory endpoints from a randomised, double-blind, placebo-controlled, phase 3 trial
2个月前
已完结
皖公网安备34019202002308
